Watchtower Advisors, LP
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 12, 2025), Watchtower Advisors, LP reported 15 stock positions worth $137.8 million. Its top holding was Axis Capital (AXS) at 18.9% of the portfolio, followed by CVS Health (CVS, 12.8%) and Hilton Worldwide (HLT, 12.7%). Compared with Q4 2024, it opened 3 new positions, sold out of 2 and reduced 6. The biggest buy was a new position in CVS Health (CVS) and the biggest sale an exit from Ftai Aviation (FTAI).
- Most Recent 13F
- Q2 2026
- Location
- OLD GREENWICH, CT
- CIK
- 0001807092
- Portfolio Value
- $137.8M (Q1 2025)
- SEC Filing
- 0001807092-25-000002 ↗ filed May 12, 2025
Holdings Value
Holdings 15 stocks · $137.8M
| AXS Axis Capital Holdings Ltd. | 18.90% | 260,000 | $26.0M | No change |
| CVS CVS Health Corp. | 12.79% | 260,000 | $17.6M | New |
| HLT Hilton Worldwide Holdings Inc. | 12.67% | 76,740 | $17.5M | No change |
| RCL Royal Caribbean Cruises Ltd. | 8.23% | 55,215 | $11.3M | No change |
| VRNA Verona Pharma Ltd. | 6.70% | 145,338 | $9.2M | Reduce -38.6% |
| APH Amphenol Corp. Class A | 6.60% | 138,700 | $9.1M | Reduce -13.3% |
| LII Lennox International Inc. | 6.13% | 15,059 | $8.4M | Reduce -31.6% |
| AVGO Broadcom Inc. | 5.95% | 48,950 | $8.2M | Reduce -30.1% |
| AZO AutoZone Inc. | 5.86% | 2,118 | $8.1M | No change |
| ATMU Atmus Filtration Technologie | 5.16% | 193,466 | $7.1M | No change |
| KVYO Klaviyo Inc. Class A | 4.06% | 185,050 | $5.6M | Reduce -37.4% |
| SLM SLM Corp. | 3.15% | 149,042 | $4.3M | New |
| GTES Gates Industrial Corp. UK Ltd. | 1.44% | 107,500 | $2.0M | New |
| MEDP Medpace Holdings Inc. | 1.22% | 5,519 | $1.7M | No change |
| ACA Arcosa Inc. | 1.14% | 20,316 | $1.6M | Reduce -28.7% |
Portfolio Sells Q4 2024 → Q1 2025
| FTAI Ftai Aviation Ltd. | Sold out | 0.00% | −12.64 |
| ALLE Allegion PLC | Sold out | 0.00% | −9.47 |
| AVGO Broadcom Inc. | Reduce -30.1% | 5.95% | −3.24 |
| KVYO Klaviyo Inc. Class A | Reduce -37.4% | 4.06% | −2.84 |
| LII Lennox International Inc. | Reduce -31.6% | 6.13% | −1.46 |
| ACA Arcosa Inc. | Reduce -28.7% | 1.14% | −0.42 |
| APH Amphenol Corp. Class A | Reduce -13.3% | 6.60% | +0.31 |
| VRNA Verona Pharma Ltd. | Reduce -38.6% | 6.70% | +0.47 |
Portfolio Buys Q4 2024 → Q1 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 11 | $179.6M | ASML, OHI, CVS, MU, PATK |
| Q1 2026 | 12 | $141.0M | ASML, OHI, PATK, CVS, SGI |
| Q4 2025 | 11 | $165.6M | ASML, CVS, PATK, OHI, APH |
| Q3 2025 | 16 | $214.3M | CVS, ASML, RCL, CLH, APH |
| Q2 2025 | 18 | $168.9M | AXS, CVS, RCL, APPF, APH |
| Q1 2025 | 15 | $137.8M | AXS, CVS, HLT, RCL, VRNA |
| Q4 2024 | 14 | $176.7M | AXS, FTAI, HLT, ALLE, AVGO |
| Q3 2024 | 15 | $215.7M | AVGO, ACGL, HLT, AXS, FTAI |
| Q2 2024 | 11 | $155.1M | AVGO, ACGL, AXS, LII, MEDP |
| Q1 2024 | 13 | $180.2M | AVGO, LII, ACGL, MEDP, SPR |